Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors-Reference-Cited by-同舟云学术

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors

Published:2017-11-28 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Riley Philip¹,Glenny Anne-Marie²,Worthington Helen V¹,Littlewood Anne¹,Fernandez Mauleffinch Luisa M¹,Clarkson Jan E³,McCabe Martin G⁴

Affiliation:

1. Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL

2. The University of Manchester; Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health; JR Moore Building Oxford Road Manchester UK M13 9PL

3. University of Dundee; Division of Oral Health Sciences; Dental Hospital & School Park Place Dundee Scotland UK DD1 4HR

4. The University of Manchester; Division of Cancer Sciences; Manchester Academic Health Science Centre Manchester UK

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011990.pub2/epdf/full

Reference135 articles.

1. Protective effect of an enteral formula containing TGF-beta(2) in the prevention of chemotherapy-induced diarrhoea: a pilot study;Antoun;e-SPEN, European e-Journal of Clinical Nutrition and Metabolism,2009

2. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT);Blazar;Blood,2006

3. In a high-dose melphalan setting, palifermin compared to placebo had no effect on oral mucositis or related patient's burden;Blijlevens;Supportive Care in Cancer,2011

4. Medical resource use of two different dosing regimens of palifermin to prevent mucositis in multiple myeloma patients receiving one-day administration of high-dose melphalan;Blijlevens;Bone Marrow Transplantation,2011

5. Randomized controlled trial of two different dosing regimens of palifermin to prevent mucositis in multiple myeloma patients receiving one-day administration of high-dose melphalan;Blijlevens;Blood,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of recombinant human interleukin-11 in preventing and treating oral mucositis after chemotherapy for patients with acute leukemia;BMC Oral Health;2023-07-12

2. Effectiveness of Application of Oral Regimen, Practicing Oral Health, Health Education, Observation (APHO) Nursing Intervention in Preventing and Managing Oral Mucositis in Children Undergoing Chemotherapy: An Interventional Study in Central India;Cureus;2023-06-24

3. Chemotherapy-Induced Oral Complications and Prophylaxis Strategies;Cancer Investigation;2023-04-20

4. Immunotherapy: A new target for cancer cure (Review);Oncology Reports;2023-03-28

5. Effect of a Novel Handheld Photobiomodulation Therapy Device in the Management of Chemoradiation Therapy-Induced Oral Mucositis in Head and Neck Cancer Patients: A Case Series Study;Photonics;2023-02-22